Skip to main content



Local Cdiff information for Colorado

Colorado

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Colorado.



Local Cdiff information for Colorado

Colorado

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Colorado.

Providers

Dr. Daniel D. Hampton, MD

Centers for Gastroenterology
3702 Timberline Rd, Suite A
Fort Collins, 80525
(970) 207-9773
FMT Provider: Yes
VISIT WEBSITE >

Regulation

C. diff Infections

Total Reported Cases: 1119
Hospital Onset: 1119
Community Onset: Not Reported
Related Deaths: Not Reported

Available Reports

Annual Progress based on SIR: 0.88
CDC STATE PROGRESS REPORT >
STATE REPORTING >

State Reporting Laws

Data Submission Required: Yes
Data Publicly Available: Yes
Data Validated: No
Facility-specific Data Publicly Reported: Yes
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: HAI Disclosure Law (House Bill 06-1045)
STATUTE >

State Contact

Tamara Hoxworth, Ph.D
CO HAI Coordinator, Patient Safety Program Epidemiologist
Colorado Department of Public Health and Environment
Health Facilities and Emergency Medical Services Division
4300 Cherry Creek Drive South
Denver, 80246
(303) 692-2930
(303) 753-6124
EMAIL TAMARA HOXWORTH, PH.D >

CLINICAL TRIALS

High- Fiber/​ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology

Official Title: Do Decreased Dietary Fat and Increased Fiber Reduce Recurrence of Clostridioides Difficile Infection in Oncology Patients?
Trial No. NCT04940468
Type: Interventional
Recruitment: Recruiting
Sponsor: University of Colorado, Denver
Contact: Catherine Lozupone
303-724-7942
EMAIL
Gender: All
Age: 9 Years and older

OpTION

Official Title: CSP #596 – Optimal Treatment for Recurrent Clostridium Difficile Infection
Trial No. NCT02667418
Type: Interventional
Recruitment: Recruiting
Sponsor: VA Office of Research and Development
Contact: Michelle Johnson
(708) 202-8387 ext 27001
EMAIL
Gender: All
Age: 18 Years and older

RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
EMAIL >
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.